View in EDS

Immune checkpoint inhibitors for advanced or metastatic basal cell carcinoma: how much evidence do we need?

Saved in:
Bibliographic Details
Title: Immune checkpoint inhibitors for advanced or metastatic basal cell carcinoma: how much evidence do we need?
Authors: Moujaess E; Department of Hematology & Oncology, Hotel Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut, 1100, Lebanon., Merhy R; Department of Dermatology & Venerology, Hotel Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut, 1100, Lebanon., Kattan J; Department of Hematology & Oncology, Hotel Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut, 1100, Lebanon., Sarkis AS; Department of Dermatology & Venerology, Hotel Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut, 1100, Lebanon., Tomb R; Department of Dermatology & Venerology, Hotel Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut, 1100, Lebanon.
Source: Immunotherapy [Immunotherapy] 2021 Oct; Vol. 13 (15), pp. 1293-1304. Date of Electronic Publication: 2021 Aug 31.
Publication Type: Journal Article; Systematic Review
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101485158 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1750-7448 (Electronic) Linking ISSN: 1750743X NLM ISO Abbreviation: Immunotherapy Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1750-7448
DOI:10.2217/imt-2021-0089